PR Newswire01.16.17
The Board of SurgaColl Technologies Ltd, the developer of collagen based products for the regeneration of human tissue, announces the appointment of William (Bill) Allan as CEO with immediate effect.
Bill is an internationally experienced medical device industry executive who has held a number of general management and leadership positions with global medical device companies, including Smith & Nephew, Angiodynamics, Orthovita, and Stryker. He has a strong track record of launching new products and building successful businesses in the sector and has worked in Europe, Africa and North America.
Educated at the University of Edinburgh (Dental Surgery), University of Capetown (MBA) and Insead Business School (AMP), Bill is a member of the council of ABHI (Association of British Healthcare Industries).
An energetic and highly commercially focused business leader, Bill has experience in a wide range of medical device industry sectors—ophthalmology, capital and consumables, orthopedics, wound care, vascular, and oncology.
Bill is an internationally experienced medical device industry executive who has held a number of general management and leadership positions with global medical device companies, including Smith & Nephew, Angiodynamics, Orthovita, and Stryker. He has a strong track record of launching new products and building successful businesses in the sector and has worked in Europe, Africa and North America.
Educated at the University of Edinburgh (Dental Surgery), University of Capetown (MBA) and Insead Business School (AMP), Bill is a member of the council of ABHI (Association of British Healthcare Industries).
An energetic and highly commercially focused business leader, Bill has experience in a wide range of medical device industry sectors—ophthalmology, capital and consumables, orthopedics, wound care, vascular, and oncology.